Using Trem2 H157Y knock-in mouse models, our data alternatively suggests non-cell autonomous benefits of sTREM2 on synaptic function and Aβ clearance, encouraging a consideration of increasing sTREM2 as a potential therapeutic strategy to treat AD. Here, TREM2 is linked to Alzheimer disease.